Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Clinical Trials | |
Description | Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about clinical trials at Novartis, including opportunities to get |
Keywords | novartis clinical trials |
WebSite | novartisclinicaltrials.com |
Host IP | 45.60.52.200 |
Location | United States |
Site | Rank |
US$735
Last updated: 2022-06-28 20:25:57
novartisclinicaltrials.com has Semrush global rank of 0. novartisclinicaltrials.com has an estimated worth of US$ 735, based on its estimated Ads revenue. novartisclinicaltrials.com receives approximately 84 unique visitors each day. Its web server is located in United States, with IP address 45.60.52.200. According to SiteAdvisor, novartisclinicaltrials.com is safe to visit. |
Purchase/Sale Value | US$735 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$20 |
Yearly Ads Revenue | US$244 |
Daily Unique Visitors | 5 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
novartisclinicaltrials.com. 86400 IN | A | IP: 45.60.52.200 | |
novartisclinicaltrials.com. 86400 IN | A | IP: 45.60.46.200 | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: a9-65.akam.net. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: a7-64.akam.net. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: dns1.novartis.com. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: a2-66.akam.net. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: a28-67.akam.net. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: a1-254.akam.net. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: dns3.novartis.com. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: a24-65.akam.net. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: dns4.novartis.com. | |
novartisclinicaltrials.com. 1800 IN | NS | NS Record: dns2.novartis.com. | |
novartisclinicaltrials.com. 86400 IN | TXT | TXT Record: f154247a-22f1-43d9-ab79-0d4bfe7d2971 | |
novartisclinicaltrials.com. 86400 IN | TXT | TXT Record: _globalsign-domain-verification=tVdVCs40EtFcHbtfINtE9aWKQFRQ7ENxR7Sr2L4_Vl |
Skip to main content Search section Global Digital ESG Media Center Careers Menu About Board of Directors Joerg Reinhardt Simon Moroney Nancy Andrews Ton Buechner Patrice Bula Elizabeth Doherty Ana de Pro Gonzalo Bridgette Heller Daniel Hochstrasser Frans van Houten Andreas von Planta Charles Sawyers William Winters Charlotte Pamer-Wieser Executive Committee Vasant Narasimhan James Bradner Victor Bulto Karen Hale Harry Kirsch Rob Kowalski Steffen Lang Klaus Moosmayer Richard Saynor John Tsai Marie-France Tschudin Lutz Hegemann Natacha Theytaz Michael Willi Strategy People and Culture Data and Digital Products Innovative Medicines Sandoz Novartis Technical Operations Global Biotech Cooperations Diversity & Inclusion Equity Diversity & Inclusion Governance and Community Inclusivity Parental Leave Society Quality Audit program Novartis Quality Management System (QMS) Product and patient safety training Regulatory inspections Product recalls Third-party suppliers About Novartis Patients |
HTTP/1.1 301 Moved Permanently Location: https://novartisclinicaltrials.com/ Content-Length: 0 Connection: close HTTP/2 302 date: Tue, 26 Oct 2021 10:47:26 GMT x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-content-type-options: nosniff content-type: text/html; charset=ISO-8859-1 strict-transport-security: max-age=63072000; includeSubdomains; preload location: https://novartisclinicaltrials.com/TrialConnectWeb/home.nov set-cookie: JSESSIONID=lci8Nkhgc6ZiJ4D6eeiSqZzjiGt5x9mq2_vqpUxuI8dHKsJfLiPz!-1215143845; path=/; HttpOnly vary: User-Agent set-cookie: TS01309237=01f27bbbb183c63f15872a33e0dd7e95c7be3cdf3b06ad63b6c513fbb88f672227b848984f2101360dd25218eb17efc874202ab2328a056a0129054ab1356592b9f4ff603b; Path=/; Domain=.novartisclinicaltrials.com; Secure; HTTPOnly set-cookie: visid_incap_1411436=3hjP2nycQcSG8dBCdvQVh73cd2EAAAAAQUIPAAAAAADOoby8LZKvxftsqwAwdzW9; expires=Wed, 26 Oct 2022 10:07:04 GMT; HttpOnly; path=/; Domain=.novartisclinicaltrials.com set-cookie: incap_ses_1211_1411436=SGWFMYKrEhlXY9I+flbOEL3cd2EAAAAAaRawPLWN7MJHZ7NhVafwOQ==; path=/; Domain=.novartisclinicaltrials.com x-cdn: Imperva x-iinfo: 1-2579708-2579709 NNNN CT(82 167 0) RT(1635245245616 0) q(0 0 2 0) r(3 3) U6 HTTP/2 405 date: Tue, 26 Oct 2021 10:47:26 GMT x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-content-type-options: nosniff content-type: text/html; charset=UTF-8 strict-transport-security: max-age=63072000; includeSubdomains; preload allow: GET vary: User-Agent set-cookie: TS01309237=01f27bbbb161fe98ce222e66b7c8be35b6f05016a7c0d5fa84549dd6024d0082b029b990802a7f30f2125c5279db9e6f8767b52538; Path=/; Domain=.novartisclinicaltrials.com; Secure; HTTPOnly set-cookie: visid_incap_1411436=NKToq4ZORjOsiwVnA+S9kL7cd2EAAAAAQUIPAAAAAABgnizzywrHFYJt80cv+8nR; expires=Wed, 26 Oct 2022 10:07:04 GMT; HttpOnly; path=/; Domain=.novartisclinicaltrials.com set-cookie: incap_ses_1211_1411436=wDfIIDb5zg/ZY9I+flbOEL7cd2EAAAAAJU8IkT/OhdQxoETC3pgHUQ==; path=/; Domain=.novartisclinicaltrials.com x-cdn: Imperva x-iinfo: 1-2579720-2579709 PNNN RT(1635245245981 0) q(0 0 0 -1) r(1 1) U6 |
Domain Name: NOVARTISCLINICALTRIALS.COM Registry Domain ID: 101284264_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-06-27T09:04:51Z Creation Date: 2003-07-29T19:20:44Z Registry Expiry Date: 2023-07-29T19:20:44Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T11:20:07Z <<< |